FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061904387> ?p ?o ?g. }

• W2061904387 endingPage "923" @default.
• W2061904387 startingPage "917" @default.
• W2061904387 abstract "1 We have used dose-response curves to quantitate the potentiation of adenosine 5′-diphosphate (ADP)-induced aggregation and thromboxane (TXA2) generation by 5-hydroxytryptamine (5-HT) and adrenaline in human citrated platelet-rich plasma. We have also quantitated the inhibition of these responses by aspirin, ketanserin and yohimbine, singly and in pairs. 2 Ketanserin (5 μm) inhibited TXA2 production and the second wave of platelet aggregation induced by a range of concentrations of ADP alone. This indicates that endogenous 5-HT, released from the platelet dense granules, contributes significantly to responses induced by ADP. 3 When 5-HT (10 μm) was added before ADP, a lower concentration of ADP was required to cause 50% aggregation and TXA2 generation. The ratio of ADP concentrations (CR) to cause 50% aggregation in the presence and absence of 5-HT was 2.1 when only added 5-HT was considered, and 5.0 when endogenous 5-HT was also taken into account. 4 Potentiation of ADP-induced aggregation by 5-HT also occurred in the presence of aspirin, resulting in a CR of 2.3. As expected, ketanserin inhibited potentiation by 5-HT in the presence and absence of aspirin. Although aspirin caused substantial inhibition of aggregation induced by ADP and 5-HT (CR 3.4), further inhibition occurred when ketanserin was also present (CR 6.5). 5 A subthreshold concentration of adrenaline (0.25 μm) caused substantial potentiation of ADP-induced aggregation in the absence (CR 4.0) and presence (CR 2.0) of aspirin. As expected, yohimbine (9 μm) inhibited this potentiation. Maximum TXA2 generation induced by ADP increased from 32.5 to 59.4 pg per 106 platelets when adrenaline was present. Aggregation induced by ADP and adrenaline was markedly inhibited by aspirin (CR 5.1) but was further inhibited when yohimbine (9 μm) was also present (CR 10.0). 6 Results from this in vitro study show ketanserin and yohimbine have the potential to be used in combination with aspirin as antithrombotic agents in vivo." @default.
• W2061904387 created "2016-06-24" @default.
• W2061904387 creator A5013890364 @default.
• W2061904387 creator A5015316103 @default.
• W2061904387 creator A5031653879 @default.
• W2061904387 creator A5066223938 @default.
• W2061904387 creator A5083494274 @default.
• W2061904387 date "1992-08-01" @default.
• W2061904387 modified "2023-10-14" @default.
• W2061904387 title "Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline" @default.
• W2061904387 cites W1506473624 @default.
• W2061904387 cites W1883766901 @default.
• W2061904387 cites W1930174851 @default.
• W2061904387 cites W1972595956 @default.
• W2061904387 cites W1975255395 @default.
• W2061904387 cites W1976047381 @default.
• W2061904387 cites W1987435896 @default.
• W2061904387 cites W1988171832 @default.
• W2061904387 cites W1988733687 @default.
• W2061904387 cites W2004489556 @default.
• W2061904387 cites W2007478842 @default.
• W2061904387 cites W2008421564 @default.
• W2061904387 cites W2008766887 @default.
• W2061904387 cites W2015518160 @default.
• W2061904387 cites W2019656309 @default.
• W2061904387 cites W2020308839 @default.
• W2061904387 cites W2023760281 @default.
• W2061904387 cites W2027625052 @default.
• W2061904387 cites W2028639923 @default.
• W2061904387 cites W2045419642 @default.
• W2061904387 cites W2052058080 @default.
• W2061904387 cites W2052860955 @default.
• W2061904387 cites W2055040123 @default.
• W2061904387 cites W2066503254 @default.
• W2061904387 cites W2072510523 @default.
• W2061904387 cites W2076882930 @default.
• W2061904387 cites W2084539833 @default.
• W2061904387 cites W2084593544 @default.
• W2061904387 cites W2086241962 @default.
• W2061904387 cites W2090708109 @default.
• W2061904387 cites W2149511595 @default.
• W2061904387 cites W2268157214 @default.
• W2061904387 cites W2304879987 @default.
• W2061904387 cites W2319834083 @default.
• W2061904387 cites W2417887381 @default.
• W2061904387 cites W2427734998 @default.
• W2061904387 cites W2444068633 @default.
• W2061904387 cites W3023253888 @default.
• W2061904387 cites W4206586840 @default.
• W2061904387 doi "https://doi.org/10.1111/j.1476-5381.1992.tb14435.x" @default.
• W2061904387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1907675" @default.
• W2061904387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1393289" @default.
• W2061904387 hasPublicationYear "1992" @default.
• W2061904387 type Work @default.
• W2061904387 sameAs 2061904387 @default.
• W2061904387 citedByCount "40" @default.
• W2061904387 countsByYear W20619043872012 @default.
• W2061904387 countsByYear W20619043872014 @default.
• W2061904387 countsByYear W20619043872015 @default.
• W2061904387 countsByYear W20619043872016 @default.
• W2061904387 countsByYear W20619043872017 @default.
• W2061904387 countsByYear W20619043872019 @default.
• W2061904387 countsByYear W20619043872020 @default.
• W2061904387 countsByYear W20619043872021 @default.
• W2061904387 countsByYear W20619043872022 @default.
• W2061904387 countsByYear W20619043872023 @default.
• W2061904387 crossrefType "journal-article" @default.
• W2061904387 hasAuthorship W2061904387A5013890364 @default.
• W2061904387 hasAuthorship W2061904387A5015316103 @default.
• W2061904387 hasAuthorship W2061904387A5031653879 @default.
• W2061904387 hasAuthorship W2061904387A5066223938 @default.
• W2061904387 hasAuthorship W2061904387A5083494274 @default.
• W2061904387 hasBestOaLocation W20619043872 @default.
• W2061904387 hasConcept C126322002 @default.
• W2061904387 hasConcept C134018914 @default.
• W2061904387 hasConcept C16613235 @default.
• W2061904387 hasConcept C170493617 @default.
• W2061904387 hasConcept C185592680 @default.
• W2061904387 hasConcept C25274449 @default.
• W2061904387 hasConcept C2775859304 @default.
• W2061904387 hasConcept C2775864247 @default.
• W2061904387 hasConcept C2776885963 @default.
• W2061904387 hasConcept C2777399203 @default.
• W2061904387 hasConcept C2777628954 @default.
• W2061904387 hasConcept C2777676773 @default.
• W2061904387 hasConcept C2777785214 @default.
• W2061904387 hasConcept C2781024287 @default.
• W2061904387 hasConcept C2993802102 @default.
• W2061904387 hasConcept C53910766 @default.
• W2061904387 hasConcept C55493867 @default.
• W2061904387 hasConcept C71924100 @default.
• W2061904387 hasConcept C86803240 @default.
• W2061904387 hasConcept C89560881 @default.
• W2061904387 hasConcept C98274493 @default.
• W2061904387 hasConceptScore W2061904387C126322002 @default.
• W2061904387 hasConceptScore W2061904387C134018914 @default.
• W2061904387 hasConceptScore W2061904387C16613235 @default.
• W2061904387 hasConceptScore W2061904387C170493617 @default.

• next